M Tomonaga
About
In The Last Decade
M Tomonaga
40 papers receiving 505 citations
Peers
Comparison fields: 5 of 72
- Hematology 223
- Molecular Biology 124
- Genetics 119
- Immunology 81
- Pulmonary and Respiratory Medicine 66
Countries citing papers authored by M Tomonaga
This map shows the geographic impact of M Tomonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Tomonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Tomonaga more than expected).
Fields of papers citing papers by M Tomonaga
This network shows the impact of papers produced by M Tomonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Tomonaga. The network helps show where M Tomonaga may publish in the future.
Co-authorship network of co-authors of M Tomonaga
This figure shows the co-authorship network connecting the top 25 collaborators of M Tomonaga. A scholar is included among the top collaborators of M Tomonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Tomonaga. M Tomonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 36 | |
| 3 | 16 | |
| 4 | 2 | |
| 5 | 180 | |
| 6 | 16 | |
| 7 | [Chemotherapy and radiation therapy]. | 2 |
| 8 | [A case of ulcerative colitis associated with Graves' disease]. | 3 |
| 9 | [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia]. | 4 |
| 10 | Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2. | 28 |
| 11 | Concomitant complete remission of APL and smoldering ATL following ATRA therapy in a patient with the two diseases simultaneously. | 7 |
| 12 | 11 | |
| 13 | [No rearrangement of the breakpoint cluster region in two juvenile chronic myeloid leukemia]. | 0 |
| 14 | 2 | |
| 15 | 21 | |
| 16 | [Normal values of F-M 100 hue test in Japanese subjects]. | 1 |
| 17 | [Headache, visual disturbance and amblyopic attack associated with sellar enlargement--primary empty sella syndrome (author's transl)]. | 3 |
| 18 | [Autopsy case of Wallenberg's syndrome caused by metastasis of lung neoplasm to the medulla oblongata]. | 4 |
| 19 | [Early resumption of activities by patients following cataract surgery]. | 5 |
| 20 | [VERTIGO AND DIZZINESS]. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.